Ferner RE[au] - Search Results

Year	Number of Results
1979	1
1981	1
1982	2
1983	1
1985	1
1986	6
1987	3
1988	7
1989	8
1990	4
1991	3
1992	5
1993	10
1994	8
1995	12
1996	4
1997	4
1998	4
1999	3
2000	6
2001	8
2002	7
2003	9
2004	7
2005	9
2006	10
2007	6
2008	7
2009	9
2010	20
2011	13
2012	15
2013	14
2014	8
2015	11
2016	10
2017	13
2018	8
2019	9
2020	12
2021	1

1

Biomarkers-A General Review.

Aronson JK, Ferner RE. Aronson JK, et al. Among authors: ferner re. Curr Protoc Pharmacol. 2017 Mar 17;76:9.23.1-9.23.17. doi: 10.1002/cpph.19. Curr Protoc Pharmacol. 2017. PMID: 28306150 Review.

2

Neurofibromatosis type 1.

Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Gutmann DH, et al. Among authors: ferner re. Nat Rev Dis Primers. 2017 Feb 23;3:17004. doi: 10.1038/nrdp.2017.4. Nat Rev Dis Primers. 2017. PMID: 28230061 Review.

3

Remdesivir in covid-19.

Ferner RE, Aronson JK. Ferner RE, et al. BMJ. 2020 Apr 22;369:m1610. doi: 10.1136/bmj.m1610. BMJ. 2020. PMID: 32321732 No abstract available.

4

Drugs and the renin-angiotensin system in covid-19.

Aronson JK, Ferner RE. Aronson JK, et al. Among authors: ferner re. BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313. BMJ. 2020. PMID: 32241880 No abstract available.

5

Neurofibromatosis type 1 (NF1): diagnosis and management.

Ferner RE, Gutmann DH. Ferner RE, et al. Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9. Handb Clin Neurol. 2013. PMID: 23931823 Review.

6

Chloroquine and hydroxychloroquine in covid-19.

Ferner RE, Aronson JK. Ferner RE, et al. BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432. BMJ. 2020. PMID: 32269046 No abstract available.

7

Medical Devices: Definition, Classification, and Regulatory Implications.

Aronson JK, Heneghan C, Ferner RE. Aronson JK, et al. Among authors: ferner re. Drug Saf. 2020 Feb;43(2):83-93. doi: 10.1007/s40264-019-00878-3. Drug Saf. 2020. PMID: 31845212 Review.

8

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A. Ferner RE, et al. J Med Genet. 2007 Feb;44(2):81-8. doi: 10.1136/jmg.2006.045906. Epub 2006 Nov 14. J Med Genet. 2007. PMID: 17105749 Free PMC article. Review.

9

Unlicensed and off-label uses of medicines: definitions and clarification of terminology.

Aronson JK, Ferner RE. Aronson JK, et al. Among authors: ferner re. Br J Clin Pharmacol. 2017 Dec;83(12):2615-2625. doi: 10.1111/bcp.13394. Epub 2017 Sep 26. Br J Clin Pharmacol. 2017. PMID: 28779556 Free PMC article. Review.

10

From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.

Ferner RE, Bakker A, Elgersma Y, Evans DGR, Giovannini M, Legius E, Lloyd A, Messiaen LM, Plotkin S, Reilly KM, Schindeler A, Smith MJ, Ullrich NJ, Widemann B, Sherman LS. Ferner RE, et al. Am J Med Genet A. 2019 Jun;179(6):1098-1106. doi: 10.1002/ajmg.a.61112. Epub 2019 Mar 25. Am J Med Genet A. 2019. PMID: 30908866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results